What Our Customers Say
Precision Health Nexus
Who We Are
January 31, 2019
The Critical Differences Between DTC and Clinical PGx Tests
In November 2018, 23andMe became the first company authorized by the U.S. Food and Drug Administration (FDA) to offer direct-to-consumer pharmacogenomic reporting. Pharmacogenomic reports use genetic testing to
Transform genetic test results into actionable information and better outcomes.
or call us to speak with our team of experts
+1 (206) 777-4063
Stay connected and subscribe to the Translational Software blog.
About Translational Software
Request a Demo